Monographs on the medicinal uses of plant drugs. Exeter, UK: European Scientific Co-op Phytother, 1997.
Tyler VE. Herbs of Choice. Binghamton, NY: Pharmaceutical Products Press, 1994.
Leung AY, Foster S. Encyclopedia of Common Natural Ingredients Used in Food, Drugs and Cosmetics. 2nd ed. New York, NY: John Wiley & Sons, 1996.
McGuffin M, Hobbs C, Upton R, Goldberg A, eds. American Herbal Products Association's Botanical Safety Handbook. Boca Raton, FL: CRC Press, LLC 1997.
Gruenwald J, Brendler T, Jaenicke C. PDR for Herbal Medicines. 1st ed. Montvale, NJ: Medical Economics Company, Inc., 1998.
Brinker F. Herb Contraindications and Drug Interactions. 2nd ed. Sandy, OR: Eclectic Medical Publications, 1998.
PremesisRx. Pharmacist's Letter / Prescriber's Letter 1999:15(12);151206.
Schneider DL, Barrett-Connor EL, Morton DJ. Thyroid hormone use and bone mineral density in elderly men. Arch Intern Med 1995;155:2005-7.
Burnham TH, ed. Drug Facts and Comparisons, Updated Monthly. Facts and Comparisons, St. Louis, MO.
Foster S, Tyler VE. Tyler's Honest Herbal, 4th ed., Binghamton, NY: Haworth Herbal Press, 1999.
Milman N, Scheibel J, Jessen O. Lysine prophylaxis in recurrent herpes simplex labialis: a double-blind, controlled crossover study. Acta Derm Venereol 1980;60:85-7.
Southwick SM, Morgan CA III, Charney DS, High JR. Yohimbine use in a natural setting: effects on post-traumatic stress disorder. Biol Psychiatr 1999;46:442-4.
Owen JA, Nakatsu SL, Fenemore J, et al. The pharmacokinetics of yohimbine in man. Eur J Clin Pharmacol 1987;3:877-82.
Cappiello A, McDougle CJ, Malison RT, et al. Yohimbine augmentation of Fluvoxamine in refactory depression: a single blind study. Biol Psychiatry 1995;38:765-7.
Montorsi F, Strambi LF, Guazzoni G, et al. Effect of yohimbine-trazodone on psychogenic impotence: a randomized, double-blind, placebo-controlled study. Urology 1994;44:732-6.
Balon R. Fluoxetine-induced sexual dysfunction and yohimbine. J Clin Psychiatry 1993;54:161-2.
Carey MP, Johnson BT. Effectiveness of yohimbine in the treatment of erectile disorder: four meta-analytic integrations. Arch Sex Behav 1996;25:341-60.
Kunellius P, Hakkinen J, Lukkarinen O. Is high-dose yohimbine hydrochloride effective in the treatment of mixed-type impotence? A prospective, randomized, controlled, double-blind crossover study. Urol 1997;49:441-4.
Wagner G, Saenz de Tejada IS. Update on male erectile dysfunction. BMJ 1998;316:678-82.
Witt DK. Yohimbine for erectile dysfuntion. J Fam Pract 1998;46:282-3.
Teloken C, Rhoden EL, Sogari P, et al. Therapeutic effects of high dose yohimbine hydrochloride on organic erectile dysfunction. J Urol 1998;159:122-4.
Ashton AK. Yohimbine in the treatment of male erectile dysfunction. Am J Psychiatr 1994;151:1397.
Jacobsen FM. Fluoxetine-induced sexual dysfunction and an open trial of yohimbine. J Clin Psychiatry 1992;53:119-22.
Hollander E, McCarley A. Yohimbine treatment of sexual side effects induced by serotonin reuptake blockers. J Clin Psychiatry 1992;53:207-9.
Harvey KV, Balon R. Clinical implications of antidepressant drug effects on sexual function. Ann Clin Psychiatry 1995;7:189-201.
Balon R. The effects of anitdepressants on human sexuality: diagnosis and management update 1999. Primary Psychiatry 1999;6:40-54.
Chevallier A. The Encyclopedia of Medicinal Plants. London, UK: Dorling Kindersley, Ltd., 1996.
Sandler B, Aronson P. Yohimbine-induced cutaneous drug eruption, progressive renal failure, and lupus-like syndrome. Urol 1993;41:343-5.
Varnell MA. Enhanced herb may help female sexual dysfunction. Reuters Health 2000;Jun 27. www.reutershealth.com/frame/eline.html (Accessed 28 June 2000).
Bucci LR. Selected herbals and human exercise performance. Am J Clin Nutr 2000;72:624S-36S..
Ernst E, Pittler MH. Yohimbine for erectile dysfunction: a systematic review and meta-analysis of randomized clinical trials. J Urol 1998;159:433-6..
Kearney T, Tu N, Haller C. Adverse drug events associated with yohimbine-containing products: a retrospective review of the California Poison Control System reported cases. Ann Pharmacother 2010;44:1022-9.
VandenBrink, B. M., Foti, R. S., Rock, D. A., Wienkers, L. C., and Wahlstrom, J. L. Prediction of CYP2D6 drug interactions from in vitro data: evidence for substrate-dependent inhibition. Drug Metab Dispos. 2012;40(1):47-53.
Abebe, W. An overview of herbal supplement utilization with particular emphasis on possible interactions with dental drugs and oral manifestations. J Dent.Hyg. 2003;77(1):37-46.
Gyllenhaal, C., Merritt, S. L., Peterson, S. D., Block, K. I., and Gochenour, T. Efficacy and safety of herbal stimulants and sedatives in sleep disorders. Sleep Med Rev. 2000;4(3):229-251.
Le Corre, P., Dollo, G., Chevanne, F., and Le Verge, R. Biopharmaceutics and metabolism of yohimbine in humans. Eur J Pharm Sci 1999;9(1):79-84.
Rasmusson, A. M., Hauger, R. L., Morgan, C. A., Bremner, J. D., Charney, D. S., and Southwick, S. M. Low baseline and yohimbine-stimulated plasma neuropeptide Y (NPY) levels in combat-related PTSD. Biol.Psychiatry 3-15-2000;47(6):526-539.
Morales, A. Yohimbine in erectile dysfunction: the facts. Int.J.Impot.Res. 2000;12 Suppl 1:S70-S74.
Mustonen, P., Savola, J., and Lassila, R. Atipamezole, an imidazoline-type alpha(2)-adrenoceptor inhibitor, binds to human platelets and inhibits their adrenaline-induced aggregation more effectively than yohimbine. Thromb.Res 8-1-2000;99(3):231-237.
Cameron, O. G., Zubieta, J. K., Grunhaus, L., and Minoshima, S. Effects of yohimbine on cerebral blood flow, symptoms, and physiological functions in humans. Psychosom.Med 2000;62(4):549-559.
Abdel-Zaher, A. O., Ahmed, I. T., and El Koussi, A. D. The potential antidiabetic activity of some alpha-2 adrenoceptor antagonists. Pharmacol Res 2001;44(5):397-409.
Papeschi, R. and Theiss, P. The effect of yohimbine on the turnover of brain catecholamines and serotonin. Eur J Pharmacol 1975;33(1):1-12.
Lebret, T., Herve, J. M., Gorny, P., Worcel, M., and Botto, H. Efficacy and safety of a novel combination of L-arginine glutamate and yohimbine hydrochloride: a new oral therapy for erectile dysfunction. Eur Urol. 2002;41(6):608-613.
Bowes, M. P., Peters, R. H., Kernan, W. J., Jr., and Hopper, D. L. Effects of yohimbine and idazoxan on motor behaviors in male rats. Pharmacol.Biochem.Behav. 1992;41(4):707-713.
Bagheri, H., Schmitt, L., Berlan, M., and Montastruc, J. L. Effect of 3 weeks treatment with yohimbine on salivary secretion in healthy volunteers and in depressed patients treated with tricyclic antidepressants. Br J Clin Pharmacol 1992;34(6):555-558.
Bagheri, H., Bompart, G., Girolami, J. P., Montastruc, J. L., and Montastruc, P. Is yohimbine-induced increase in salivary secretion a kinin-dependent mechanism? Fundam.Clin Pharmacol 1992;6(1):17-20.
Albus, M., Zahn, T. P., and Breier, A. Anxiogenic properties of yohimbine. I. Behavioral, physiological and biochemical measures. Eur.Arch.Psychiatry Clin.Neurosci. 1992;241(6):337-344.
Albus, M., Zahn, T. P., and Breier, A. Anxiogenic properties of yohimbine. II. Influence of experimental set and setting. Eur Arch Psychiatry Clin Neurosci. 1992;241(6):345-351.
Swann, A. C., Birnbaum, D., Jagar, A. A., Dougherty, D. M., and Moeller, F. G. Acute yohimbine increases laboratory-measured impulsivity in normal subjects. Biol.Psychiatry 5-15-2005;57(10):1209-1211.
Ostojic, S. M. Yohimbine: the effects on body composition and exercise performance in soccer players. Res Sports Med 2006;14(4):289-299.
Adeniyi, A. A., Brindley, G. S., Pryor, J. P., and Ralph, D. J. Yohimbine in the treatment of orgasmic dysfunction. Asian J Androl 2007;9(3):403-407.
Grossman, E., Rea, R. F., Hoffman, A., and Goldstein, D. S. Yohimbine increases sympathetic nerve activity and norepinephrine spillover in normal volunteers. Am J Physiol 1991;260(1 Pt 2):R142-R147.
Berlan, M., Galitzky, J., Riviere, D., Foureau, M., Tran, M. A., Flores, R., Louvet, J. P., Houin, G., and Lafontan, M. Plasma catecholamine levels and lipid mobilization induced by yohimbine in obese and non-obese women. Int.J Obes. 1991;15(5):305-315.
Murburg, M. M., Villacres, E. C., Ko, G. N., and Veith, R. C. Effects of yohimbine on human sympathetic nervous system function. J Clin Endocrinol.Metab 1991;73(4):861-865.
Powers, M. B., Smits, J. A., Otto, M. W., Sanders, C., and Emmelkamp, P. M. Facilitation of fear extinction in phobic participants with a novel cognitive enhancer: a randomized placebo controlled trial of yohimbine augmentation. J Anxiety.Disord. 2009;23(3):350-356.
Giampreti, A., Lonati, D., Locatelli, C., Rocchi, L., and Campailla, M. T. Acute neurotoxicity after yohimbine ingestion by a body builder. Clin Toxicol.(Phila) 2009;47(8):827-829.
Bloomer, R. J., Canale, R. E., Blankenship, M. M., Hammond, K. G., Fisher-Wellman, K. H., and Schilling, B. K. Effect of the dietary supplement Meltdown on catecholamine secretion, markers of lipolysis, and metabolic rate in men and women: a randomized, placebo controlled, cross-over study. Lipids Health Dis 2009;8:32.
Fleurence, R., Williamson, R., Jing, Y., Kim, E., Tran, Q. V., Pikalov, A. S., and Thase, M. E. A systematic review of augmentation strategies for patients with major depressive disorder. Psychopharmacol.Bull. 2009;42(3):57-90.
Myers, A. and Barrueto, F., Jr. Refractory priapism associated with ingestion of yohimbe extract. J Med Toxicol. 2009;5(4):223-225.
Holmes, A. and Quirk, G. J. Pharmacological facilitation of fear extinction and the search for adjunct treatments for anxiety disorders--the case of yohimbine. Trends Pharmacol Sci 2010;31(1):2-7.
Berlin, I., Crespo-Laumonnier, B., Cournot, A., Landault, C., Aubin, F., Legrand, J. C., and Puech, A. J. The alpha 2-adrenergic receptor antagonist yohimbine inhibits epinephrine-induced platelet aggregation in healthy subjects. Clin Pharmacol.Ther. 1991;49(4):362-369.
Guthrie, S. K., Hariharan, M., and Grunhaus, L. J. Yohimbine bioavailability in humans. Eur.J Clin Pharmacol 1990;39(4):409-411.
Swann, A. C. Mechanisms of impulsivity in bipolar disorder and related illness. Epidemiol.Psichiatr.Soc. 2010;19(2):120-130.
Shibao, C., Okamoto, L. E., Gamboa, A., Yu, C., Diedrich, A., Raj, S. R., Robertson, D., and Biaggioni, I. Comparative efficacy of yohimbine against pyridostigmine for the treatment of orthostatic hypotension in autonomic failure. Hypertension 2010;56(5):847-851.
Ernst, E., Posadzki, P., and Lee, M. S. Complementary and alternative medicine (CAM) for sexual dysfunction and erectile dysfunction in older men and women: an overview of systematic reviews. Maturitas 2011;70(1):37-41.
Ho, C. C. and Tan, H. M. Rise of herbal and traditional medicine in erectile dysfunction management. Curr Urol.Rep. 2011;12(6):470-478.
Meyerbroeker, K., Powers, M. B., van, Stegeren A., and Emmelkamp, P. M. Does yohimbine hydrochloride facilitate fear extinction in virtual reality treatment of fear of flying? A randomized placebo-controlled trial. Psychother.Psychosom. 2012;81(1):29-37.
Soeter, M. and Kindt, M. Stimulation of the noradrenergic system during memory formation impairs extinction learning but not the disruption of reconsolidation. Neuropsychopharmacology 2012;37(5):1204-1215.
Okamoto, L. E., Shibao, C., Gamboa, A., Choi, L., Diedrich, A., Raj, S. R., Black, B. K., Robertson, D., and Biaggioni, I. Synergistic effect of norepinephrine transporter blockade and alpha-2 antagonism on blood pressure in autonomic failure. Hypertension 2012;59(3):650-656.
Cimolai, N. and Cimolai, T. Yohimbine use for physical enhancement and its potential toxicity. J Diet.Suppl 2011;8(4):346-354.
Sonda, L. P., Mazo, R., and Chancellor, M. B. The role of yohimbine for the treatment of erectile impotence. J Sex Marital Ther. 1990;16(1):15-21.
Bagheri, H., Berlan, M., Montastruc, J. L., and Montastruc, P. Yohimbine and lacrimal secretion. Br J Clin Pharmacol. 1990;30(1):151-152.
Landis, E. and Shore, E. Yohimbine-induced bronchospasm. Chest 1989;96(6):1424.
Berlin, I., Crespo-Laumonnier, B., Turpin, G., and Puech, A. J. The alpha-2 adrenoceptor antagonist yohimbine does not facilitate weight loss but blocks adrenaline induced platelet aggregation in obese subjects. Therapie 1989;44(4):301.
Susset, J. G., Tessier, C. D., Wincze, J., Bansal, S., Malhotra, C., and Schwacha, M. G. Effect of yohimbine hydrochloride on erectile impotence: a double-blind study. J Urol. 1989;141(6):1360-1363.
Chatelut, E., Rispail, Y., Berlan, M., and Montastruc, J. L. Yohimbine increases human salivary secretion. Br.J Clin Pharmacol. 1989;28(3):366-368.
Montastruc, P., Berlan, M., and Montastruc, J. L. Effects of yohimbine on submaxillary salivation in dogs. Br J Pharmacol 1989;98(1):101-104.
Anonymous. Yohimbine: time for resurrection? Lancet 11-22-1986;2(8517):1194-1195.
Reid, K., Surridge, D. H., Morales, A., Condra, M., Harris, C., Owen, J., and Fenemore, J. Double-blind trial of yohimbine in treatment of psychogenic impotence. Lancet 8-22-1987;2(8556):421-423.
Galitzky, J., Taouis, M., Berlan, M., Riviere, D., Garrigues, M., and Lafontan, M. Alpha 2-antagonist compounds and lipid mobilization: evidence for a lipid mobilizing effect of oral yohimbine in healthy male volunteers. Eur.J Clin Invest 1988;18(6):587-594.
Charney, D. S., Price, L. H., and Heninger, G. R. Desipramine-yohimbine combination treatment of refractory depression. Implications for the beta-adrenergic receptor hypothesis of antidepressant action. Arch.Gen.Psychiatry 1986;43(12):1155-1161.
Braddock, L., Cowen, P. J., Elliott, J. M., Fraser, S., and Stump, K. Binding of yohimbine and imipramine to platelets in depressive illness. Psychol.Med 1986;16(4):765-773.
Dwoskin, L. P., Neal, B. S., and Sparber, S. B. Evidence for antiserotonergic properties of yohimbine. Pharmacol Biochem.Behav. 1988;31(2):321-326.
Morales, A., Condra, M., Owen, J. A., Surridge, D. H., Fenemore, J., and Harris, C. Is yohimbine effective in the treatment of organic impotence? Results of a controlled trial. J Urol. 1987;137(6):1168-1172.
Berlin, I., Stalla-Bourdillon, A., Thuillier, Y., Turpin, G., and Puech, A. J. [Lack of efficacy of yohimbine in the treatment of obesity]. J Pharmacol 1986;17(3):343-347.
Bolme, P., Corrodi, H., Fuxe, K., Hokfelt, T., Lidbrink, P., and Goldstein, M. Possible involvement of central adrenaline neurons in vasomotor and respiratory control. Studies with clonidine and its interactions with piperoxane and yohimbine. Eur J Pharmacol 1974;28(1):89-94.
Miller, W. W., Jr. Afrodex in the treatment of male impotence: a double-blind cross-over study. Curr.Ther.Res.Clin Exp. 1968;10(7):354-359.
Ho, A. K., Hoffman, D. B., Gershon, S., and Loh, H. H. Distribution and metabolism of tritiated yohimbine in mice. Arch.Int.Pharmacodyn.Ther 1971;194(2):304-315.
Morales, A., Surridge, D. H., Marshall, P. G., and Fenemore, J. Nonhormonal pharmacological treatment of organic impotence. J Urol. 1982;128(1):45-47.
Goldberg, M. R. and Robertson, D. Yohimbine: a pharmacological probe for study of the alpha 2- adrenoreceptor. Pharmacol Rev. 1983;35(3):143-180.
Motulsky, H. J., Shattil, S. J., and Insel, P. A. Characterization of alpha 2-adrenergic receptors on human platelets using [
Charney, D. S., Heninger, G. R., and Sternberg, D. E. Assessment of alpha 2 adrenergic autoreceptor function in humans: effects of oral yohimbine. Life Sci 6-7-1982;30(23):2033-2041.
Anden, N. E., Pauksens, K., and Svensson, K. Selective blockade of brain alpha 2-autoreceptors by yohimbine: effects on motor activity and on turnover of noradrenaline and dopamine. J Neural Transm. 1982;55(2):111-120.
Boon, N. A., Elliott, J. M., Grahame-Smith, D. G., John-Green, T., and Stump, K. A comparison of alpha 2-adrenoreceptor binding characteristics of intact human platelets identified by [3H]-yohimbine and [3H]- dihydroergocryptine. J Auton.Pharmacol 1983;3(2):89-95.
Andrejak, M., Ward, M., and Schmitt, H. Cardiovascular effects of yohimbine in anaesthetized dogs. Eur.J Pharmacol 10-28-1983;94(3-4):219-228.
Braddock, L. E., Cowen, P. J., Elliott, J. M., Fraser, S., and Stump, K. Changes in the binding to platelets of [3H]imipramine and [3H]yohimbine in normal subjects taking amitriptyline. Neuropharmacology 1984;23(2B):285-286.
Brodde, O. E., Anlauf, M., Arroyo, J., Wagner, R., Weber, F., and Buck, K. D. Hypersensitivity of adrenergic receptors and blood-pressure response to oral yohimbine in orthostatic hypotension. N.Engl.J Med 4-28-1983;308(17):1033-1034.
Charney, D. S., Heninger, G. R., and Redmond, D. E., Jr. Yohimbine induced anxiety and increased noradrenergic function in humans: effects of diazepam and clonidine. Life Sci. 7-4-1983;33(1):19-29.
Montastruc, J. L., Puech, A. J., Clanet, M., Guiraud-Chaumeil, B., and Rascol, A. [Yohimbine in treatment of Parkinson's disease. Preliminary results (author's transl)]. Nouv.Presse Med 4-11-1981;10(16):1331-1332.
Morales, A., Surridge, D. H., and Marshall, P. G. Yohimbine for treatment of impotence in diabetes. N.Engl.J Med 11-12-1981;305(20):1221.
Bourin, M., Malinge, M., and Guitton, B. Provocative agents in panic disorder. Therapie 1995;50(4):301-306.
Knoll, L. D., Benson, R. C., Jr., Bilhartz, D. L., Minich, P. J., and Furlow, W. L. A randomized crossover study using yohimbine and isoxsuprine versus pentoxifylline in the management of vasculogenic impotence. J Urol. 1996;155(1):144-146.
Betz, J. M., White, K. D., and der Marderosian, A. H. Gas chromatographic determination of yohimbine in commercial yohimbe products. J AOAC Int 1995;78(5):1189-1194.
Bagheri, H., Chale, J. J., Guyen, L. N., Tran, M. A., Berlan, M., and Montastruc, J. L. Evidence for activation of both adrenergic and cholinergic nervous pathways by yohimbine, an alpha 2-adrenoceptor antagonist. Fundam.Clin Pharmacol 1995;9(3):248-254.
Morgan, C. A., III, Grillon, C., Southwick, S. M., Nagy, L. M., Davis, M., Krystal, J. H., and Charney, D. S. Yohimbine facilitated acoustic startle in combat veterans with post- traumatic stress disorder. Psychopharmacology (Berl) 1995;117(4):466-471.
Kennedy, S. H., Gnam, W., Ralevski, E., and Brown, G. M. Melatonin responses to clonidine and yohimbine challenges. J Psychiatry Neurosci. 1995;20(4):297-304.
Musso, N. R., Vergassola, C., Pende, A., and Lotti, G. Yohimbine effects on blood pressure and plasma catecholamines in human hypertension. Am J Hypertens. 1995;8(6):565-571.
Morgan, C. A., III, Southwick, S. M., Grillon, C., Davis, M., Krystal, J. H., and Charney, D. S. Yohimbine-facilitated acoustic startle reflex in humans. Psychopharmacology (Berl) 1993;110(3):342-346.
Adler, L. E., Hoffer, L., Nagamoto, H. T., Waldo, M. C., Kisley, M. A., and Giffith, J. M. Yohimbine impairs P50 auditory sensory gating in normal subjects. Neuropsychopharmacology 1994;10(4):249-257.
Biaggioni, I., Robertson, R. M., and Robertson, D. Manipulation of norepinephrine metabolism with yohimbine in the treatment of autonomic failure. J Clin Pharmacol. 1994;34(5):418-423.
Kenney, W. L., Zappe, D. H., Tankersley, C. G., and Derr, J. A. Effect of systemic yohimbine on the control of skin blood flow during local heating and dynamic exercise. Am J Physiol 1994;266(2 Pt 2):H371-H376.
Friesen, K., Palatnick, W., and Tenenbein, M. Benign course after massive ingestion of yohimbine. J Emerg.Med 1993;11(3):287-288.
Bierer, L. M., Aisen, P. S., Davidson, M., Ryan, T. M., Stern, R. G., Schmeidler, J., and Davis, K. L. A pilot study of oral physostigmine plus yohimbine in patients with Alzheimer disease. Alzheimer Dis.Assoc.Disord. 1993;7(2):98-104.
Balon, R. Fluoxetine-induced sexual dysfunction and yohimbine. J Clin Psychiatry 1993;54(4):161-162.
Siddiqui, M. A., More-O'Ferrall, D., Hammod, R. S., Baime, R. V., and Staddon, A. P. Agranulocytosis associated with yohimbine use. Arch.Intern.Med 6-10-1996;156(11):1235-1237.
Mann, K., Klingler, T., Noe, S., Roschke, J., Muller, S., and Benkert, O. Effects of yohimbine on sexual experiences and nocturnal penile tumescence and rigidity in erectile dysfunction. Arch.Sex Behav. 1996;25(1):1-16.
Montague, D. K., Barada, J. H., Belker, A. M., Levine, L. A., Nadig, P. W., Roehrborn, C. G., Sharlip, I. D., and Bennett, A. H. Clinical guidelines panel on erectile dysfunction: summary report on the treatment of organic erectile dysfunction. The American Urological Association. J Urol. 1996;156(6):2007-2011.
Rowland, D. L., Kallan, K., and Slob, A. K. Yohimbine, erectile capacity, and sexual response in men. Arch Sex Behav 1997;26(1):49-62.
Bremner, J. D., Innis, R. B., Ng, C. K., Staib, L. H., Salomon, R. M., Bronen, R. A., Duncan, J., Southwick, S. M., Krystal, J. H., Rich, D., Zubal, G., Dey, H., Soufer, R., and Charney, D. S. Positron emission tomography measurement of cerebral metabolic correlates of yohimbine administration in combat-related posttraumatic stress disorder. Arch.Gen.Psychiatry 1997;54(3):246-254.
Sturgill, M. G., Grasing, K. W., Rosen, R. C., Thomas, T. J., Kulkarni, G. D., Trout, J. R., Maines, M., and Seibold, J. R. Yohimbine elimination in normal volunteers is characterized by both one- and two-compartment behavior. J Cardiovasc.Pharmacol. 1997;29(6):697-703.
Gurguis, G. N., Vitton, B. J., and Uhde, T. W. Behavioral, sympathetic and adrenocortical responses to yohimbine in panic disorder patients and normal controls. Psychiatry Res. 6-16-1997;71(1):27-39.
Bagheri, H., Schmitt, L., Berlan, M., and Montastruc, J. L. A comparative study of the effects of yohimbine and anetholtrithione on salivary secretion in depressed patients treated with psychotropic drugs. Eur.J Clin Pharmacol. 1997;52(5):339-342.
Southwick, S. M., Krystal, J. H., Bremner, J. D., Morgan, C. A., III, Nicolaou, A. L., Nagy, L. M., Johnson, D. R., Heninger, G. R., and Charney, D. S. Noradrenergic and serotonergic function in posttraumatic stress disorder. Arch.Gen.Psychiatry 1997;54(8):749-758.
Vogt, H. J., Brandl, P., Kockott, G., Schmitz, J. R., Wiegand, M. H., Schadrack, J., and Gierend, M. Double-blind, placebo-controlled safety and efficacy trial with yohimbine hydrochloride in the treatment of nonorganic erectile dysfunction. Int J Impot.Res 1997;9(3):155-161.
Piletz, J. E., Segraves, K. B., Feng, Y. Z., Maguire, E., Dunger, B., and Halaris, A. Plasma MHPG response to yohimbine treatment in women with hypoactive sexual desire. J Sex Marital Ther. 1998;24(1):43-54.
Jordan, J., Shannon, J. R., Biaggioni, I., Norman, R., Black, B. K., and Robertson, D. Contrasting actions of pressor agents in severe autonomic failure. Am J Med. 1998;105(2):116-124.
Mosqueda-Garcia, R., Fernandez-Violante, R., Tank, J., Snell, M., Cunningham, G., and Furlan, R. Yohimbine in neurally mediated syncope. Pathophysiological implications. J Clin Invest 11-15-1998;102(10):1824-1830.
Mazo R and Sonda LP. A prospective double blind trial of yohimbine for erectile impotence [abstract]. 79th Annual Meeting of the American Urological Association, Baltimore 1984;234/A.
Balon R. The effects of anitdepressants on human sexuality: Diagnosis and management update 1999. Primary Psychology 1999;6(11):40-54.
Yan J and Wang W. A comparative effects of Sildenafil (Viagra) and yohimbine for the treatment of erectile dysfunction. Chinese J or Andrology. 2000;14(2):103-5.
Riley AJ, Goodman R, Kellett JM, and et al. Double blind trial of yohimbine hydrochloride in the treatment of erection inadequacy. Sexual Marital Ther 1989;4(1):17-26.
Melman A. The effects of yohimbine upon sexual function: a double-blind study [abstract]. 79th Annual Meeting of the American Urological Association, Baltimore :302/A.
Cohen PA, Wang YH, Maller G, DeSouza R, Khan IA. Pharmaceutical quantities of yohimbine found in dietary supplements in the USA. Drug Test Anal. 2015 Sep 22.
Hostettmann K, Marston A, Ndjoko K, Wolfender J-L. The Potential of African Plants as a Source of Drugs. Curr Org Chem 2000;4:973-1010.
Ruck B, Shih RD, Marcus SM. Hypertensive crisis from herbal treatment of impotence. Am J Emerg Med. 1999;17:317-318.
Wylie KR. Yohimbine and sinusitis. Br J Psychiatry. 1996;169(3):384-5.
EFSA Panel on Food Additives and Nutrient Sources Added to Food (ANS). Scientific Opinion on the evaluation of the safety in use of Yohimbe (Pausinystalia yohimbe (K. Schum.) Pierre ex Beille). EFSA J. 2013;11(7):3302.
Scheinin H, Virtanen R. Effects of yohimbine and idazoxan on monoamine metabolites in rat cerebrospinal fluid. Life Sci. 1986 Oct 20;39(16):1439-46.
Sanacora G, Berman RM, Cappiello A, et al. Addition of the alpha2-antagonist yohimbine to fluoxetine: effects on rate of antidepressant response. Neuropsychopharmacology. 2004;29(6):1166-71.
Herman AM, Critchley HD, Duka T. The impact of yohimbine-induced arousal on facets of behavioural impulsivity. Psychopharmacology (Berl). 2019;236(6):1783-1795.
Metz S, Waiblinger-Grigull T, Schulreich S, et al. Effects of hydrocortisone and yohimbine on decision-making under risk. Psychoneuroendocrinology. 2020;114:104589.
Kuehl LK, Deuter CE, Hellmann-Regen J, Kaczmarczyk M, Otte C, Wingenfeld K. Enhanced noradrenergic activity by yohimbine and differential fear conditioning in patients with major depression with and without adverse childhood experiences. Prog Neuropsychopharmacol Biol Psychiatry. 2020;96:109751.
Le Corre P, Parmer RJ, Kailasam MT, et al. Human sympathetic activation by alpha2-adrenergic blockade with yohimbine: Bimodal, epistatic influence of cytochrome P450-mediated drug metabolism. Clin Pharmacol Ther. 2004;76(2):139-53.
Mueller-Schoell A, Michelet R, Weinelt F, Kloft C, Mikus G. CYP2D6 phenotype explains reported yohimbine concentrations in four severe acute intoxications. Arch Toxicol. 2021.
Bharucha AE, Skaar T, Andrews CN, et al Relationship of cytochrome P450 pharmacogenetics to the effects of yohimbine on gastrointestinal transit and catecholamines in healthy subjects. Neurogastroenterol Motil. 2008;20(8):891-9.
Zhu L, Han X, Zhu J, Du L, Liu L, Gong W. Severe acute intoxication with yohimbine: Four simultaneous poisoning cases. Forensic Sci Int. 2021;320:110705.
Schmauss M, Laakmann G, Dieterle D. Effects of alpha 2-receptor blockade in addition to tricyclic antidepressants in therapy-resistant depression. J Clin Psychopharmacol. 1988;8(2):108-11.
Wibowo DNSA, Soebadi DM, Soebadi MA. Yohimbine as a treatment for erectile dysfunction: A systematic review and meta-analysis. Turk J Urol 2021;47(6):482-488.
Barnes ME, Cowan CR, Boag LE, et al. Effects of Acute Yohimbine Hydrochloride Supplementation on Repeated Supramaximal Sprint Performance. Int J Environ Res Public Health 2022;19(3):1316.
Deuter CE, Smit J, Kaczmarczyk M, Wingenfeld K, Otte C, Kuehl LK. Approach-avoidance tendencies in depression and childhood trauma: No effect of noradrenergic stimulation. Compr Psychoneuroendocrinol 2021;8:100077.
Elbe A, Foerster KI, Blank A, et al. Evaluation of CYP2C19 activity using microdosed oral omeprazole in humans. Eur J Clin Pharmacol 2022;78(6):975-987.
Haron MH, Dale O, Martin K, et al. Evaluation of the Herb-Drug Interaction Potential of Commonly Used Botanicals on the US Market with Regard to PXR- and AhR-Mediated Influences on CYP3A4 and CYP1A2. J Diet Suppl 2022.
Sperl MFJ, Panitz C, Skoluda N, et al. Alpha-2 Adrenoreceptor Antagonist Yohimbine Potentiates Consolidation of Conditioned Fear. Int J Neuropsychopharmacol 2022;25(9):759-773.
Hodapp B, Haggerty A, Feldman R, Timpe J. Intracranial hemorrhage after a single dose of Yohimbine in a chronic user of clonidine. Am J Emerg Med 2022;62:145.
Vay M, Meyer MJ, Blank A, et al. Oral yohimbine as a new probe drug to predict CYP2D6 activity: results of a fixed-sequence phase I trial. Clin Pharmacokinet. 2020;59(7):927-939.
CONDITIONS OF USE AND IMPORTANT INFORMATION: This information is meant to supplement, not replace advice from your doctor or healthcare provider and is not meant to cover all possible uses, precautions, interactions or adverse effects. This information may not fit your specific health circumstances. Never delay or disregard seeking professional medical advice from your doctor or other qualified health care provider because of something you have read on WebMD. You should always speak with your doctor or health care professional before you start, stop, or change any prescribed part of your health care plan or treatment and to determine what course of therapy is right for you.
This copyrighted material is licensed from Therapeutic Research Center, LLC. Information from this source is evidence-based and objective, and without commercial influence. For professional medical information on natural medicines, see Natural Medicines Comprehensive Database Professional Version.
Licensed from Therapeutic Research Center, LLC
Copyright © 1995-2025 by Therapeutic Research Center, LLC. All Rights Reserved.